Evidence map›Paper›PMID 33900080›Full record

ArticleThe journal of physical chemistry letters2021

Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.

Laura Zanetti-Polzi, Micholas Dean Smith, Chris Chipot, James C Gumbart, Diane L Lynch, Anna Pavlova, Jeremy C Smith, Isabella Daidone

Open access · hybridAbstract read
In one paragraph

Article in The journal of physical chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diphenyl Diselenide and SARS-CoV-2:Journal of chemical information and modeling · 2023
    Article
  8. Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor.ACS pharmacology & translational science · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Characterization of Phytochemicals inFrontiers in chemistry · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Laura Zanetti-PolziCenter S3, CNR Institute of Nanoscience, Via Campi 213/A, I-41125 Modena, Italy.ORCID http://orcid.org/0000-0002-2550-4796
Micholas Dean SmithDepartment of Biochemistry, Molecular and Cellular Biology, The University of Tennessee, Knoxville, 309 Ken and Blaire Mossman Bldg., 1311 Cumberland Avenue, Knoxville, Tennessee 37996, United States.ORCID http://orcid.org/0000-0002-0777-7539
Chris ChipotUMR 7019, Université de Lorraine, Laboratoire International Associé CNRS, 54506 Vandœuvre-lès-Nancy, France.ORCID http://orcid.org/0000-0002-9122-1698
James C GumbartSchool of Physics, Georgia Institute of Technology, Atlanta Georgia 30332, United States.ORCID http://orcid.org/0000-0002-1510-7842
Diane L LynchSchool of Physics, Georgia Institute of Technology, Atlanta Georgia 30332, United States.
Anna PavlovaSchool of Physics, Georgia Institute of Technology, Atlanta Georgia 30332, United States.
Jeremy C SmithDepartment of Biochemistry, Molecular and Cellular Biology, The University of Tennessee, Knoxville, 309 Ken and Blaire Mossman Bldg., 1311 Cumberland Avenue, Knoxville, Tennessee 37996, United States.ORCID http://orcid.org/0000-0002-2978-3227
Isabella DaidoneDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, I-67010 L'Aquila, Italy.ORCID http://orcid.org/0000-0001-8970-8408
Georgia Institute of Technology · USCentre National de la Recherche Scientifique · FRIstituto Nanoscienze · ITOak Ridge National Laboratory · USUniversity of L'Aquila · ITUniversity of Tennessee at Knoxville · US

Funding

Altering Hepatitis B Virus assembly through pharmacological interventionR01AI148740 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI GUMBART, JAMES C. · 2020 to 2024
$2.0M
NIAID NIH HHS R01 AI148740
6 · The paper itself

Abstract

The catalytic reaction in SARS-CoV-2 main protease is activated by a proton transfer (PT) from Cys145 to His41. The same PT is likely also required for the covalent binding of some inhibitors. Here we use a multiscale computational approach to investigate the PT thermodynamics in the apo enzyme and in complex with two potent inhibitors, N3 and the α-ketoamide

Indexed as

Drug DesignAntiviral AgentsBiocatalysisCatalytic DomainCoronavirus M ProteinsCOVID-19HumansMolecular Dynamics SimulationProtease InhibitorsProtonsQuantum TheorySARS-CoV-2ThermodynamicsViral Matrix ProteinsAntiviral AgentsCoronavirus M Proteinsmembrane protein, SARS-CoV-2Protease InhibitorsProtonsViral Matrix Proteins

Identifiers

PMID33900080
PMCPMC8097931
OpenAlexW3101252836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.